BioCentury | Jun 20, 2019
Targets & Mechanisms

Moving beyond the active site: why allostery is newly in fashion

A new crop of companies is creating tools to systematize development of allosteric protein inhibitors, finally moving industry beyond the one-off compounds that have been found by accident. Allosteric pockets on proteins have long been...
BioCentury | Jul 30, 2012
Emerging Company Profile

BioMotiv: Bridging the gap

...Catalyst Growth Partners . He is joined by CSO David U'Prichard, who was CEO of 3-Dimensional Pharmaceuticals Inc....
BioCentury | Mar 15, 2012
Strategy

One gap, two approaches

...Growth Partners, which provides advisory services for emerging companies. U'Prichard is the former CEO of 3-Dimensional Pharmaceuticals Inc....
BioCentury | Oct 1, 2007
Clinical News

InQu regulatory update

...extremities and pelvis. The product is a biopolymer composite of hyaluronic acid entangled with a 3-dimensional...
BioCentury | Dec 19, 2005
Company News

Galapagos NV, Cresset BioMolecular Discovery Ltd. deal

...the technology for medicinal chemistry projects for itself and third parties. Field Templater identifies the 3-dimensional...
BioCentury | Dec 5, 2005
Company News

Cresset BioMolecular Discovery Ltd. sales and marketing update

...Cresset launched its Field Templater in silico technology to identify the 3-dimensional conformation of therapeutics bound...
BioCentury | Dec 13, 2004
Finance

Ebb & Flow

...a venture partner. He is president of Druid Consulting, and before that was CEO of 3-Dimensional...
BioCentury | Jul 26, 2004
Company News

EC Technologies LLC, SomaLogic deal

...technology is used to identify aptamers, which are short strings of nucleotides that fold into 3-dimensional...
BioCentury | Jul 19, 2004
Company News

Linguagen management update

...N.J. Business: Other Hired: Scott Horvitz as CFO, formerly CFO, corporate secretary and treasurer of 3-Dimensional Pharmaceuticals Inc. WIR...
BioCentury | Jul 19, 2004
Company News

PamGene International B.V., University of Nottingham deal

...PamGene licensed its PamStation 3-dimensional, flow-through microarray platform to the university to automate multiplex amplifiable probe...
Items per page:
1 - 10 of 155
BioCentury | Jun 20, 2019
Targets & Mechanisms

Moving beyond the active site: why allostery is newly in fashion

A new crop of companies is creating tools to systematize development of allosteric protein inhibitors, finally moving industry beyond the one-off compounds that have been found by accident. Allosteric pockets on proteins have long been...
BioCentury | Jul 30, 2012
Emerging Company Profile

BioMotiv: Bridging the gap

...Catalyst Growth Partners . He is joined by CSO David U'Prichard, who was CEO of 3-Dimensional Pharmaceuticals Inc....
BioCentury | Mar 15, 2012
Strategy

One gap, two approaches

...Growth Partners, which provides advisory services for emerging companies. U'Prichard is the former CEO of 3-Dimensional Pharmaceuticals Inc....
BioCentury | Oct 1, 2007
Clinical News

InQu regulatory update

...extremities and pelvis. The product is a biopolymer composite of hyaluronic acid entangled with a 3-dimensional...
BioCentury | Dec 19, 2005
Company News

Galapagos NV, Cresset BioMolecular Discovery Ltd. deal

...the technology for medicinal chemistry projects for itself and third parties. Field Templater identifies the 3-dimensional...
BioCentury | Dec 5, 2005
Company News

Cresset BioMolecular Discovery Ltd. sales and marketing update

...Cresset launched its Field Templater in silico technology to identify the 3-dimensional conformation of therapeutics bound...
BioCentury | Dec 13, 2004
Finance

Ebb & Flow

...a venture partner. He is president of Druid Consulting, and before that was CEO of 3-Dimensional...
BioCentury | Jul 26, 2004
Company News

EC Technologies LLC, SomaLogic deal

...technology is used to identify aptamers, which are short strings of nucleotides that fold into 3-dimensional...
BioCentury | Jul 19, 2004
Company News

Linguagen management update

...N.J. Business: Other Hired: Scott Horvitz as CFO, formerly CFO, corporate secretary and treasurer of 3-Dimensional Pharmaceuticals Inc. WIR...
BioCentury | Jul 19, 2004
Company News

PamGene International B.V., University of Nottingham deal

...PamGene licensed its PamStation 3-dimensional, flow-through microarray platform to the university to automate multiplex amplifiable probe...
Items per page:
1 - 10 of 155